Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Liver Fibrosis”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Testing effectiveness (Phase 2)Study completedNCT05663944
What this trial is testing

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

Who this might be right for
Advanced Chronic Liver Disease
Nottingham University Hospitals NHS Trust 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT05782283
What this trial is testing

Detect Advanced Liver Disease Via AI-enabled Electrocardiogram

Who this might be right for
Cirrhosis
Mayo Clinic 279
Not applicableStudy completedNCT04435054
What this trial is testing

Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospices Civils de Lyon 1,000
Not applicableStudy completedNCT04173520
What this trial is testing

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

Who this might be right for
HCC
Egyptian Liver Hospital 2,326
Not applicableStudy completedNCT05097963
What this trial is testing

Evaluate Liver Stiffness With Shear Wave Elastography

Who this might be right for
Chronic Liver DiseaseAdvanced FibrosisAdvanced Cirrhosis
Mayo Clinic 63
Not applicableStudy completedNCT01789008
What this trial is testing

Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.

Who this might be right for
AlcoholismLiver DiseaseLiver Fibrosis
Rennes University Hospital 300
Not applicableLooking for participantsNCT05502198
What this trial is testing

Relevance of Sarcopenia in Advanced Liver Disease

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSarcopenia+1 more
Linkoeping University 150
Not applicableStudy completedNCT04576572
What this trial is testing

Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerAdvanced Adult Hepatocellular Carcinoma+3 more
Inonu University 424
Testing effectiveness (Phase 2)Looking for participantsNCT05028829
What this trial is testing

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

Who this might be right for
Liver FibrosesCirrhosis
Raymond Chung 60
Not applicableEnded earlyNCT07102979
What this trial is testing

Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response

Who this might be right for
Liver Fibrosis
Chang Gung Memorial Hospital 19
Not applicableActive Not RecruitingNCT06604923
What this trial is testing

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

Who this might be right for
Primary Biliary Cholangitis (PBC)CirrhosisCholestasis+2 more
University of Aarhus 30
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableEnrolling By InvitationNCT07312136
What this trial is testing

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosisAdvanced Fibrosis+6 more
Linkoeping University 317
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Post-approval studies (Phase 4)WithdrawnNCT02206932
What this trial is testing

The Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV CDC Category A1
University of California, San Francisco
Early research (Phase 1)Study completedNCT01503749
What this trial is testing

Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Seoul National University Hospital 9
Large-scale testing (Phase 3)Looking for participantsNCT05201404
What this trial is testing

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma 471
Post-approval studies (Phase 4)Study completedNCT02344719
What this trial is testing

Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

Who this might be right for
CirrhosisPortal Hypertension
Medical University of Vienna 30
Next Page